Clariane account plan
European care community leader
At a glance
Clariane (formerly Korian) runs 1,215 nursing homes, clinics and care sites in six European countries: €5,310m FY2025 revenue, 70,685 employees.
Clariane SE, formerly Korian and renamed in 2023 when it became a purpose-driven company, is a European specialist in non-acute care: medicalised nursing homes, specialty and mental health clinics, and alternative living and home-based care. At 31 December 2025 it ran 1,215 facilities with about 89,400 beds in France, Germany, Belgium, the Netherlands, Italy and Spain, employed 70,685 people (65,034 FTEs) and cared for 842,566 patients and residents. FY2025 revenue was €5,310m (+4.5% organic), EBITDA excl. IFRS 16 €594m and attributable net profit excl. IFRS 16 €36m. Revenue is mainly regulated, with a care portion funded by public payers. It is listed on Euronext Paris; Predica (Crédit Agricole Assurances) and HLD Europe each hold over 10% of capital.
Business units
Long-term Care
€3,387m FY2025 revenue, about 64% of revenue656 medicalised nursing homes with 61,789 beds under Korian (Germany, Belgium, France, Italy, Netherlands), Seniors Residencias (Spain) and Rosorum (Netherlands). Occupancy averaged 91% in 2025 and 91.7% in H1 2026, and homes are becoming more medicalised, with more short stays after hospital and respite care.
Specialty Care
€1,287m FY2025 revenue, 24% of revenue279 facilities with 14,230 beds in post-acute (SMR) care, mental health, outpatient care and social services: Inicea in France, Kormed in Italy, and Ita Salud Mental, Grupo 5, Cian and Iterias in Spain, where Clariane is the leading mental health provider. The French SMR pricing reform hit H1 2025 and was corrected in H2 2025; revenue rose to €676m in H1 2026.
Community Care
€636m FY2025 revenue, about 12% of revenue280 alternative living facilities with 13,343 beds, including Âges & Vie shared houses in France, shared housing and domiciliary care in Germany, and home care in Belgium and the Netherlands. Revenue fell 3% after the Petits-fils home-care network was sold in July 2025, while organic growth was 9%.
France
€2,264m FY2025 revenue, 43% of revenue559 facilities and 24,157 employees across Korian, Inicea and Âges & Vie; EBITDAR margin fell to 20.2% in 2025 because of the SMR reform. Led by Aymeric Mathias (Chairman, Clariane France).
Germany
€1,316m FY2025 revenue, 25% of revenue227 facilities and 21,584 employees in nursing homes, shared housing and home care; EBITDAR margin rose to 24.0% as tariffs caught up with 2022-2023 wage increases. Led by Christian Gharieb.
Benelux
€846m FY2025 revenue, 16% of revenueBelgium (117 facilities) and the Netherlands (59 facilities), with EBITDAR margin of 23.3%; nine Belgian buildings were sold and leased back in December 2025. Led by Dominiek Beelen.
Italy
€618m FY2025 revenue, 12% of revenue89 facilities with Korian nursing homes and Kormed healthcare, including robotic surgery introduced in 2025. Led by Federico Guidoni.
Spain
€267m FY2025 revenue, 5% of revenue164 facilities, mostly mental health and social care plus Seniors Residencias nursing homes. Chaired by Anne-Charlotte Dymny, also Group CIO.
Strategic priorities
- Succeeding Together plan 2025-2028
- Revenue CAGR around 4%, pre-IFRS 16 EBITDA CAGR 7-9%, opco EBITDA CAGR 11-14% and Wholeco leverage around 5x at end-2028 (adjusted in July 2026 from around 4.5x), self-financed.
- Margin recovery
- Boissard says margin recovery is set to continue in 2026, driven by performance plans particularly in Germany and France; pre-IFRS 16 EBITDA margin reached 10.4% in H1 2026.
- Care closer to home and outpatient
- Strategy pillars include personalised care closer to home and the shift to outpatient models; outpatient revenue in France grew 16% in 2025.
- Talent and training
- Clariane University ran more than 863,000 training hours in 2025 with 7,743 employees on qualifying training paths, and aims for 75% of facility directors promoted from within by end-2026.
- Quality of care
- Targets include an NPS of at least 40 (+45 in 2025) and a lost-time accident frequency rate of 29 (28 in 2025); 99% of nursing homes and clinics are ISO 9001 certified.
- Digital, AI and geroscience
- Boissard names the technology shift as a priority to 2029, with a dedicated team working with digital and AI experts, alongside geroscience and prevention.
Latest results
In H1 2026 revenue was €2,699m, +1.6% reported and +4.6% organic (volumes +1.6%, price +3.0%, scope -3.0% from the 2025 disposals). Pre-IFRS 16 EBITDA rose 14.9% pro forma to €280m (margin 10.4% vs 9.5%) and opco EBITDA 25.1% pro forma to €168m. Nursing home occupancy reached 91.7% (90.5%). The attributable net loss was €48m (IFRS) after €51m of non-recurring costs and €100m of financial expenses. Net financial debt fell to €3,020m and liquidity rose to €1,736m. The 2023-2026 and 2025-2028 targets were confirmed, with leverage targets adjusted to below 5.5x at end-2026 and around 5x at end-2028.
Investments and deals
- €1bn disposal programme completed
- The €1.5bn plan to strengthen the financial structure was completed in June 2025, six months early, ending with the sale of Petits-fils (€345m enterprise value) at an average EBITDA multiple of around 14x.
- Bond refinancing
- In H1 2026 Clariane raised more than €1bn in bonds: €730m 6.875% senior notes due 2031 and a €333m 7.875% hybrid, after first ratings of B+ (S&P) and B2 (Moody's).
- Capex programme
- Capex of about €300m a year, split evenly between maintenance and development; 33 facilities opened over the 12 months to June 2026.
- Real estate sale and leaseback
- Nine Belgian buildings sold to Care Property Invest in December 2025 (€143m total) with 20-year leases; the real estate portfolio was valued at €2,428m in H1 2026.
- France support-function plan
- A 2026 plan cut 71 net jobs in French support functions, centralising accounting in Aix-en-Provence and closing the Devecey site.
Challenges and risks
- Regulated pricing reforms
- The French SMR financing reform caused pricing anomalies and underfunding of facilities opened 2023-2025, corrected by the authorities in H2 2025.
- Recruitment and labour costs
- Labour costs are 61% of revenue, and recruitment and retention of trained care staff is a key risk across all facilities.
- Leverage and covenants
- Net debt excl. IFRS 16 was €3,055m at end-2025, and no dividend is paid while Wholeco leverage is above 4.0x; the covenant was reset to 7.5x at 30 June 2026.
- Quality of care and reputation
- Falls, malnutrition, abuse, fire and legionellosis are named operational risks, along with reputational damage to the sector.
- Cybersecurity and data
- IT, cybersecurity and personal data protection are listed among the operational risks.
What leadership says
“Margin recovery is set to continue and intensify in 2026, driven by the various performance plans under way, particularly in Germany and France.”
“The first-half results reflect the sound execution of our roadmap and confirm the solidity of our fundamentals and our embedded growth potential.”
“growth prospects, improving the quality of care, developing our workforce and stabilising the Group's financial situation”
Where a supplier can help
- Staffing and training tools
- With labour at 61% of revenue and recruitment a key risk, workforce scheduling, recruitment and training solutions support the talent priority.
- Care-quality and digital health
- The digital, AI and geroscience priority and quality targets (NPS, falls, malnutrition) suit care-documentation, monitoring and fall-prevention technology.
- Shared services and finance automation
- Centralising French accounting in Aix-en-Provence and the margin recovery plans open room for finance automation and procurement tools.
- Facilities and energy
- About €300m of yearly capex, renovations and energy-emission targets fit construction, maintenance and energy-efficiency suppliers.
- Cybersecurity for care sites
- Cybersecurity and personal data are named risks across about 1,200 facilities, an opening for security and data-protection vendors.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Clariane?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- 2025 Universal Registration Document (Annual Financial Report and Integrated Report)
- Clariane (formerly Korian, renamed in 2023) is a European non-acute care group and purpose-driven company: 1,215 facilities, about 89,400 beds, 70,685 employees (65,034 FTEs) in six countries, and 842,566 patients and residents cared for in 2025.
- FY2025 revenue €5,310m (+0.5% reported, +4.5% organic); EBITDAR excl. IFRS 16 €1,159m (21.8% margin); EBITDA excl. IFRS 16 €594m (11.2%, +3.1% pro forma); attributable net profit excl. IFRS 16 €36m vs a €20m loss in 2024.
- Three business lines by revenue: Long-term Care €3,387m, Specialty Care €1,287m, Community Care €636m. By country: France 43% (€2,265m), Germany 25% (€1,316m), Benelux 16% (€846m), Italy 12% (€618m), Spain 5% (€267m).
- Brands: Korian (nursing homes in Germany, Belgium, France, Italy, Netherlands), Seniors Residencias (Spain), Rosorum (Netherlands), Âges & Vie shared houses (France); specialty care under Inicea (France), Kormed (Italy), Ita Salud Mental, Grupo 5, Cian and Iterias (Spain).
- The €1.5bn plan to strengthen the financial structure (Nov 2023) was completed six months early; the €1bn gross disposal programme closed with the sale of Petits-fils (€345m enterprise value) at an average EBITDA multiple of around 14x.
- Net debt excl. IFRS 16 fell €390m to €3,055m; Wholeco leverage 5.1x (5.8x in 2024) against a 6.5x covenant; a €500m 2030 bond (7.875% coupon) restored market access. No dividend while Wholeco leverage is above 4.0x.
- 2025-2028 targets ("Succeeding Together"): revenue CAGR around 4%, pre-IFRS 16 EBITDA CAGR 7-9%, opco EBITDA CAGR 11-14%, Wholeco leverage around 4.5x at end-2028; capex about €300m a year, split evenly between maintenance and development.
- Key risks: quality of care and abuse, reputation, recruitment (labour costs are 61% of revenue), regulated pricing reforms (the French SMR financing reform hurt H1 2025), cybersecurity, liquidity and covenants.
- Quality metrics: NPS +45, lost-time accident frequency rate 28 (31 in 2024), 7,743 employees on qualifying training paths, 99% of nursing homes and clinics ISO 9001 certified.
- 2026 Half-Year Financial Report
- H1 2026 revenue €2,699m, +1.6% reported and +4.6% organic (volumes +1.6%, price +3.0%, scope and other -3.0% from the 2025 disposals).
- Long-term Care €2,024m and Specialty Care €676m; by country France €1,129m, Germany €678m, Benelux €438m, Italy €305m, Spain €149m.
- Pre-IFRS 16 EBITDA €280m (+14.9% pro forma), margin 10.4% vs 9.5%; opco EBITDA €168m (+25.1% pro forma), margin 6.2%; EBITDAR €563m.
- Nursing home occupancy 91.7% (90.5% in H1 2025); network of 1,213 facilities and just over 89,000 beds; 45 facilities sold or closed and 33 opened in 12 months.
- Attributable net loss €48m (IFRS) and €42m pre-IFRS 16, after €51m of non-recurring costs and €100m of financial expenses.
- More than €1bn raised in bonds in H1: €730m 6.875% senior notes due 2031, a €333m 7.875% hybrid to repay the ODIRNANE; first ratings B+ (S&P) and B2 (Moody's); GBP 200m green hybrid repaid.
- Net financial debt €3,020m (€3,559m a year earlier); liquidity €1,736m; Wholeco leverage 4.9x reported, 5.4x adjusted; covenant reset to 7.5x at 30 June 2026.
- France support-function plan (PSE): 71 net job losses, accounting centralised in Aix-en-Provence, Devecey site closed.
- 2023-2026 and 2025-2028 targets confirmed; leverage targets adjusted to below 5.5x at end-2026 and around 5x at end-2028 after the GBP hybrid refinancing.
- Sophie Boissard (DG de Clariane) : "Notre feuille de route a été bien comprise par les marchés !" (BFM Business Ecorama)
- Sophie Boissard (CEO) on BFM Business Ecorama, 4 March 2026, the week after the FY2025 results; interview in French, quotes translated.
- She calls 2025 a financial turning point: the 2023 plan was completed, debt and leverage cut, and inaugural S&P and Moody's ratings secured for safer bond-market access.
- Occupancy is above 91%, and at 92% in nursing homes; she targets 4-5% organic growth to 2028 and beyond in a domestic, multi-local business not exposed to international trade.
- Inflation: energy is hedged for three years; most tariffs are indexed to inflation (directly in Germany, Belgium and the Netherlands); about 40% of prices are set by Clariane.
- Germany revenue rose 8% in 2025, 90% from tariffs catching up with the 2022-2023 wage increases.
- The French SMR financing reform forgot facilities opened or extended between 2022 and 2024 (20% of the network), a €20m EBITDA hit in H1 2025 now corrected.
- About €1bn of non-core disposals at 14x; the group operates eight activity segments, none above 25% of revenue.
- Free cash flow was not yet positive in 2025 and will be in 2026; "Réussir ensemble" targets 7-8% EBITDA growth a year (11-14% after internal rents) and leverage around 4.5x by 2028.
- Sophie Boissard (Clariane) : "Les investisseurs réalisent que notre secteur est incontournable !" (Boursorama, La grande interview)
- Sophie Boissard (CEO) in Boursorama's Grande Interview, recorded after the Q1 2025 revenue release (YouTube upload 14 October 2025); in French, quotes translated.
- She frames Clariane as 1,200 facilities in Europe and 63,000 employees, with about 500 structures in France plus 250 Petits-fils home-care agencies at the time.
- The 2023 €1.5bn plan included a €300m capital increase; 60% of the disposal programme was done, with €506m of gross disposals in 2024 and about €100m more by end-Q1 2025.
- Q1 revenue growth of about 5% came from both volumes (ambulatory care, home care, occupancy) and tariff catch-up after the 2022-2023 inflation.
- Group nursing home occupancy is 90.4%, France between 88% and 89%; about 12% of French capacity is still in double rooms.
- Nursing homes are becoming "small hospitals" with more short stays after hospital and respite care.
- Target: margin recovery of about 1-1.5 points by 2026 and net financial debt below €3bn with Wholeco leverage below 5x at end-2026.
- Staffing: Clariane trained 7,000 people through its own university; NPS was +44, "10 to 20 points better than the sector".
- Priorities to 2029: meeting ageing and chronic-disease needs (+30% by 2030, +50% by 2040), and digital and AI in care, with geroscience and prevention.
Questions about Clariane
What does Clariane do?
Clariane, formerly Korian, runs medicalised nursing homes, specialty and mental health clinics, and alternative living and home care in France, Germany, Belgium, the Netherlands, Italy and Spain.
What was Clariane's revenue in 2025?
FY2025 revenue was €5,310m, +4.5% organic, with EBITDA excl. IFRS 16 of €594m. H1 2026 revenue was €2,699m.
How many employees does Clariane have?
70,685 employees (65,034 FTEs) at 31 December 2025.
What is Clariane's strategy?
The 2025-2028 Succeeding Together plan targets revenue growth around 4% a year and opco EBITDA growth of 11-14%, through occupancy, pricing, outpatient care and alternative living, while reducing leverage.
Who leads Clariane?
Sophie Boissard has been CEO since 2016, and Sylvia Metayer has chaired the board since 14 May 2025.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)